1.Reply to: "NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues"

Ji, D, Cheng, G, Lau     More...

Ji, D, Cheng, G, Lau, G     Less

JOURNAL OF HEPATOLOGY[0168-8278], Published 2021, Volume 74, Issue 2, Pages 484-485

收錄情况： WOS SCOPUS

WOS核心合集引用: 8  2023影響因子:  26.8  发表年影響因子:  30.083 

2.Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study

Ji, D, Qin, EQ, Xu,     More...

Ji, D, Qin, EQ, Xu, J, Zhang, DW, Cheng, G, Wang, YD, Lau, G     Less

JOURNAL OF HEPATOLOGY[0168-8278], Published 2020, Volume 73, Issue 2, Pages 451-453

收錄情况： WOS SCOPUS

WOS核心合集引用: 385  2023影響因子:  26.8  发表年影響因子:  25.083 

3.Reply to: 'No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease'

Ji, D, Xu, J, Qin, E     More...

Ji, D, Xu, J, Qin, EQ, Zhang, DW, Cheng, G, Wang, YD, Lau, G     Less

JOURNAL OF HEPATOLOGY[0168-8278], Published 2020, Volume 73, Issue 3, Pages 718-719

收錄情况： WOS SCOPUS

WOS核心合集引用: 6  2023影響因子:  26.8  发表年影響因子:  25.083